We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Sekisui XenoTech Establishes Method for High Aldehyde Oxidase and Xanthine Oxidase Activity in Pooled Human Liver Test Systems

Product News   Aug 14, 2017

 
Sekisui XenoTech Establishes Method for High Aldehyde Oxidase and Xanthine Oxidase Activity in Pooled Human Liver Test Systems

Image Credit: Sekisui XenoTech

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100

Product News

BioVersys has reached a major milestone by entering clinical development with the start of Phase 1 testing of BV100 in healthy volunteers.

READ MORE

Abcam’s New Premium-Grade Bioactive Proteins, for Drug Discovery, Development and Manufacturing

Product News

Abcam’s new premium-grade proteins are manufactured in mammalian cell lines under animal-free conditions limiting endotoxins to ultra-low levels (< 5 EU/mg).

READ MORE

Movers and Shakers in Biobusiness Report

Product News

The seventh annual Movers and Shakers in BioBusiness report highlights 30 examples of resourceful leaders in the UK bioscience sector.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE